Medicine and Health Campaign

Advancing diabetes research

World-renowned scientists at the University of Minnesota are leading the way in developing advanced treatments and potential cures for type 1 and 2 diabetes, thanks to a community of charitable supporters.

Type 1 diabetes is caused by the immune system’s destruction of insulin-producing cells, known as islets, in the pancreas. University researchers established a standardized treatment for human islet-cell transplantation, which is now in the final stages of review by the U.S. Food and Drug Administration to become a routine medical procedure for treating type 1 diabetes in certain patients.

Philanthropic support makes discovery possible

With the help of charitable gifts, U scientists and physicians in the Schulze Diabetes Institute and Stem Cell Institute are:

  • seeking ways to prevent islets from being killed by the body and protect replaced or regenerated islets and organs in patients with type 1 diabetes
  • establishing an unlimited source of islet cells for transplantation using pig islets and creating insulin-producing islet cells from adult stem cells
  • participating in TrialNet, a global network of researchers working on diabetes prevention and early treatment
  • developing more effective ways to prevent, better manage, and reverse type 2 diabetes
  • providing surgical solutions and developing new drugs to address the challenges of diabetes

Your support can change lives. Give today.

View additional stories on Diabetes

Managing the ABCs of nutrition can help people who have diabetes avoid serious complications. Read More »
A U researcher takes a new approach to the most important meal of the day. Read More »
Pioneering islet cell research at the U of M also has led to better health after pancreatitis treatment. Read More »